|
|
|
|
|
Detail |
| hsa-miR-183 |
|
Unspecified |
MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias. |
2004 |
|
|
|
|
|
|
| hsa-miR-183 |
|
Unspecified |
Altered retinal microRNA expression profile in a mouse model of retinitis pigmentosa. |
2007 |
|
|
|
|
|
|
| hsa-miR-183 |
|
Unspecified |
Identification by Real-time PCR of 13 mature microRNAs differentially expressed in colorectal cancer and non-tumoral tissues. |
2006 |
|
|
|
|
|
|
| hsa-miR-183 |
|
Unspecified |
MicroRNA let-7b targets important cell cycle molecules in malignant melanoma cells and interferes with anchorage-independent growth. |
2008 |
|
|
|
|
|
|
| hsa-miR-183 |
|
Unspecified |
MicroRNA 133B targets pro-survival molecules MCL-1 and BCL2L2 in lung cancer. |
2009 |
|
|
|
|
|
|
| hsa-miR-183 |
|
Unspecified |
Diagnostic and prognostic implications of microRNA profiling in prostate carcinoma. |
2009 |
|
|
|
|
|
|
| hsa-miR-183 |
|
Unspecified |
Effect of miRNA-10b in regulating cellular steatosis level by targeting PPAR-alpha expression, a novel mechanism for the pathogenesis of NAFLD |
2009 |
|
|
|
|
|
|
| hsa-miR-183 |
|
Unspecified |
Characterization of global microRNA expression reveals oncogenic potential of miR-145 in metastatic colorectal cancer |
2009 |
|
|
|
|
|
|
| hsa-miR-183 |
|
Unspecified |
Profiling microRNA expression in hepatocellular carcinoma reveals microRNA-224 up-regulation and apoptosis inhibitor-5 as a microRNA-224-specific target. |
2008 |
|
|
|
|
|
|
| hsa-miR-183 |
|
Unspecified |
MicroRNA expression and identification of putative miRNA targets in ovarian cancer. |
2008 |
|
|
|
|
|
|
| hsa-miR-183 |
|
Unspecified |
Common microRNA signature in mouse models of retinal degeneration. |
2008 |
|
|
|
|
|
|
| hsa-miR-183 |
|
Causal |
MicroRNA-183 regulates Ezrin expression in lung cancer cells. |
2008 |
|
|
|
|
|
|
| hsa-miR-183 |
|
Unspecified |
Over- and under-expressed microRNAs in human colorectal cancer. |
2009 |
|
|
|
|
|
|
| hsa-miR-183 |
|
Unspecified |
Restoration of tumour suppressor hsa-miR-145 inhibits cancer cell growth in lung adenocarcinoma patients with epidermal growth factor receptor mutation. |
2009 |
|
|
|
|
|
|